Literature DB >> 9691139

Prevalence of the G20210A polymorphism in the 3'-untranslated region of the prothrombin gene in different human populations.

R F Franco1, S E Santos, J Elion, M H Tavella, M A Zago.   

Abstract

Recently a novel polymorphism in the 3'-untranslated region of the prothrombin gene (a G to A transition at position 20210) was discovered, and an association with venous thrombosis and cardiovascular disease was found. The prevalence of the polymorphic allele in different human populations is unknown. We investigated the prevalence of the A 20210 allele of the prothrombin gene in 420 unrelated individuals (840 chromosomes) who belong to four different ethnic groups: Whites, African and Brazilian Blacks, Asians and Amerindians. PCR amplification followed by HindIII digestion was employed. The polymorphism was found in heterozygosity in 2 out of 120 Whites or a prevalence of 1.6% (allele frequency 0.8%), similar to that observed for other Caucasian populations. The A allele was absent among the other ethnic groups analyzed. Our data indicate that in non-Caucasians the prevalence of the 20210 G-->A mutation in the prothrombin gene, if any, must be extremely low. The absence of this novel genetic risk factor for venous and arterial thrombotic disease among non-Caucasians may contribute to explaining geographical and ethnic differences in the risk of vascular disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691139     DOI: 10.1159/000040854

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  8 in total

1.  Deep upper limb and jugular venous thrombosis in dilated cardiomyopathy.

Authors:  P Venugopalan; A K Meharali; A K Agarwal
Journal:  J R Soc Med       Date:  1999-11       Impact factor: 5.344

2.  Prevalence of the prothrombin G20210A polymorphism in the Lebanese population: use of a reverse hybridization strip assay approach.

Authors:  Amira S Sabbagh; Georges Ibrahim; Ziad Kanaan; Dina M R Shammaa; Rabab Abdel Khalek; Mona Ghasham; Layal Greige; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2007-12-08       Impact factor: 2.316

3.  Increased Factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients.

Authors:  Adriano de Paula Sabino; Daniela Amorim Melgaço Guimarães; Daniel Dias Ribeiro; Sabrina Guimarães Paiva; Luci Maria Sant'Ana Dusse; Maria das Graças Carvalho; Ana Paula Fernandes
Journal:  J Thromb Thrombolysis       Date:  2007-03-31       Impact factor: 2.300

4.  Personalized healthcare in clotting disorders.

Authors:  Haifeng M Wu; Lihui Xu; Daniel D Sedmak; Clay B Marsh; Mark W Wurster
Journal:  Per Med       Date:  2010-01       Impact factor: 2.512

5.  The Prevalence of the Prothrombin (F2) 20210G>A Mutation in a Cohort of Sri Lankan Patients with Thromboembolic Disorders.

Authors:  K M D Gunathilake; U N D Sirisena; P K D Nisansala; H W W Goonasekera; R W Jayasekara; V H W Dissanayake
Journal:  Indian J Hematol Blood Transfus       Date:  2014-09-02       Impact factor: 0.900

6.  Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-11-28       Impact factor: 2.576

7.  An Altered Treatment Plan Based on Direct to Consumer (DTC) Genetic Testing: Personalized Medicine from the Patient/Pin-cushion Perspective.

Authors:  Jessica D Tenenbaum; Andra James; Kristin Paulyson-Nuñez
Journal:  J Pers Med       Date:  2012-10-30

Review 8.  Inherited thrombophilia: key points for genetic counseling.

Authors:  Elizabeth Varga
Journal:  J Genet Couns       Date:  2007-05-01       Impact factor: 2.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.